Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives Jul 24, 2023 06:00AM
Pre-Open Stock Movers 10/12: (DDS) (DOYU) (TWLO) Higher; (ATXI) (PCG) Lower (more...) Oct 12, 2020 09:29AM
Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary) Feb 11, 2019 07:30AM
Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary) Feb 11, 2019 07:30AM
Fortress Biotech (FBIO) Agrees to Sell Avenue Therapeutics (ATXI) to Cipla Ltd. Subsidiary, InvaGen Pharmaceuticals Inc. Nov 13, 2018 06:37AM


Nov 13, 2018 06:30AM InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
Nov 13, 2018 06:30AM InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
Feb 9, 2018 10:00AM Avenue Therapeutics, Inc. (Nasdaq: ATXI) to Ring The Nasdaq Stock Market Closing Bell